EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD

被引：0
|
作者：
Fiore, F. [1 ]
Viviani, S. [2 ]
Luminari, S. [3 ]
Levis, A. [4 ]
Di Raimondo, F. [5 ]
Merli, F. [6 ]
Vitolo, U. [7 ]
Bolis, S. [8 ]
Federico, M. [8 ]
Gallamini, A. [1 ]
机构：
[1] Az Osped S Croce & Carle Cuneo, Dept Hematol, Cuneo, CN, Italy
[2] Ist Nazl Tumori Milano, Dept Med Oncol, Milan, Italy
[3] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
[4] Az Osped S Antonio & Biagio, Dept Hematol, Alessandria, Italy
[5] Univ Catania, Hematol Chair, Catania, Italy
[6] Arcispedale S Maria Nuova, Dept Hematol, Reggio Emilia, Italy
[7] Az Osped S Giovanni Battista, Dept Hematol, Turin, Italy
[8] Osped San Gerardo, Dept Hematol, Monza, Italy
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C061
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] EARLY INTERIM FDG-PET IN ADVANCED-STAGE HODGKIN LYMPHOMA (HL). LONG-TERM RESULTS OF THE ITALIAN-DANISH COOPERATIVE STUDY
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Pregno, P.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Torchio, P.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 191 - 191
  • [32] The role of FDG-PET in early therapy assessment and follow-up of patients with advanced Hodgkin Lymphoma treated with BEACOPP
    Kahraman, D.
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Mocikova, H.
    Klaskova, K.
    Dedeckova, K.
    Eich, H.
    Boell, B.
    Dietlein, M.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S251 - S251
  • [33] Predictive value of interim FDG-PET during neoajuvant chemotherapy in patients treated for locally advanced breast cancer.
    Musto, A.
    Zamagni, C.
    Ambrosini, V.
    Nanni, C.
    Rosati, M.
    Kumar, R.
    Alavi, A.
    Sansovini, M.
    Farsad, M.
    Montini, G.
    Franchi, R.
    Palucci, A.
    Pettinato, C.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S200 - S200
  • [34] Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2016, 33 (01) : 1 - 4
  • [35] EARLY CHEMOTHERAPY INTENSIFICATION WITH ESCALATED BEACOPP IN ADVANCED-STAGE HODGKIN LYMPHOMA WITH A POSITIVE INTERIM PET-CT AFTER 2 ABVD CYCLES: LONG-TERM RESULTS OF THE GITIL/FIL HD 0607 TRIAL
    Gallamini, A.
    Rossi, A.
    Patti, K.
    Picardi, M.
    Romano, A.
    Cantonetti, M.
    La Nasa, G.
    Trentin, L.
    Bolis, S.
    Rapezzi, D.
    Viviani, S.
    Gianni, A. M.
    Zoli, V.
    Gottardi, D.
    Tarella, C.
    Gavarotti, P.
    Corradini, P.
    Cimminiello, M.
    Schiavotto, C.
    Parvis, G.
    Zanotti, R.
    Gini, G.
    Ferreri, A. J.
    Viero, P.
    Miglino, M.
    Billio, A.
    Avigdor, A.
    Prosperini, G.
    Bergesio, F.
    Pavoni, C.
    Rambaldi, A.
    HAEMATOLOGICA, 2017, 102 : 145 - 146
  • [36] FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Plutschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1270 - 1274
  • [37] Semi-quantitative parameters could improve positive predictive value of interim FDG-PET/CT in Hodgkin Lymphoma
    Annunziata, S.
    Cuccaro, A.
    Hohaus, S.
    Giordano, A.
    Rufini, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S312 - S312
  • [38] The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy
    Savage, K. J.
    Connors, J. M.
    Klasa, R. J.
    Hoskins, P.
    Shenkier, T. N.
    Gascoyne, R. D.
    Bhimji, S.
    Pickles, T.
    Benard, F.
    Wilson, D.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Advanced stage Hodgkin lymphoma: The predictive value on treatment outcome of early FDG-PET scan is independent of and superior to IPS score.
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    D'Amore, F.
    Nassi, L.
    Hansen, M.
    Vitolo, U.
    Kamper, P.
    Trentin, L.
    Stelitano, C.
    Di Raimondo, F.
    Sancetta, R.
    Luminari, S.
    Viviani, S.
    Iannitto, E.
    Levis, A.
    BLOOD, 2006, 108 (11) : 228B - 228B
  • [40] The value of dual point interim FDG-PET/CT assessment in a patient with advanced Hodgkin's lymphoma (HL) with bulky masses treated with ABVD chemotherapy
    Zaucha, J.
    Malkowski, B.
    Gallamini, A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S27 - S28
12345